Allspring Global Investments
HCAT icon

Allspring Global Investments’s Health Catalyst HCAT Stock Holding History

Allspring Global Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,272
Closed -$14.5K – 2520
2024
Q2 		$14.5K Buy
+2,272
New +$14.6K ﹤0.01% 2168
2023
Q4 		– Sell
-2,146
Closed -$21.7K – 2438
2023
Q3 		$21.7K Buy
+2,146
New +$25.6K ﹤0.01% 2495
2022
Q2 		– Sell
-10,442
Closed -$272K – 2787
2022
Q1 		$272K Buy
10,442
+646
+7% +$18.3K ﹤0.01% 2467
2021
Q4 		$388K Buy
+9,796
New +$446K ﹤0.01% 2402

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allspring Global Investments's HCAT Position: Q3 2024 in Review

Allspring Global Investments sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 2,272 shares — an estimated $14.5K sold.

Allspring Global Investments first reported a position in HCAT in Q4 2021 and held it in 4 quarters. The position peaked at $388K in Q4 2021. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • Allspring Global Investments reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 2,272 Health Catalyst shares in Q3 2024, an estimated $14.5K.
  • Allspring Global Investments first reported a position in Health Catalyst in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Health Catalyst position peaked at $388K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.